ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05012	Parkinson's disease	23/129	155/7206	2.10204822309e-15
ko00190	Oxidative phosphorylation	21/129	127/7206	4.15111609857e-15
ko05010	Alzheimer's disease	24/129	202/7206	8.11360978769e-14
ko05016	Huntington's disease	24/129	215/7206	3.28627299734e-13
ko04260	Cardiac muscle contraction	17/129	98/7206	9.23793429426e-13
ko04932	Non-alcoholic fatty liver disease (NAFLD)	18/129	182/7206	2.89440530582e-09
ko05410	Hypertrophic cardiomyopathy (HCM)	13/129	100/7206	2.00213386391e-08
ko05414	Dilated cardiomyopathy	12/129	112/7206	6.26305812668e-07
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	10/129	79/7206	1.20523773005e-06
ko04723	Retrograde endocannabinoid signaling	13/129	175/7206	1.32602035752e-05
ko01200	Carbon metabolism	11/129	128/7206	1.62484766762e-05
ko00030	Pentose phosphate pathway	5/129	32/7206	0.000232394198881
ko04261	Adrenergic signaling in cardiomyocytes	12/129	205/7206	0.000286486669284
ko00010	Glycolysis / Gluconeogenesis	7/129	74/7206	0.000332660230037
ko04921	Oxytocin signaling pathway	11/129	209/7206	0.00124792516247
ko00710	Carbon fixation in photosynthetic organisms	4/129	27/7206	0.00125003295649
ko04964	Proximal tubule bicarbonate reclamation	4/129	29/7206	0.00164559769927
ko00680	Methane metabolism	4/129	34/7206	0.00299905759323
ko00020	Citrate cycle (TCA cycle)	4/129	35/7206	0.00333972604446
ko04510	Focal adhesion	10/129	240/7206	0.0106739290854
ko05200	Pathways in cancer	2/129	492/7206	0.0121476031974
ko04512	ECM-receptor interaction	5/129	79/7206	0.013338463576
ko01230	Biosynthesis of amino acids	5/129	85/7206	0.0178427859638
ko00500	Starch and sucrose metabolism	3/129	35/7206	0.0241760967704
ko04020	Calcium signaling pathway	10/129	265/7206	0.027759908542
ko00051	Fructose and mannose metabolism	3/129	42/7206	0.0387651892356